Zinc affects nuclear factor kappa b and DNA methyltransferase activity in C3H cancer fibroblast cells induced by a 2100 MHz electromagnetic field

Electromagnetic biology and medicine · 2022 · Mixed · Low evidence

← Research stream
MixedLow evidencePaper 935

In C3H cancer fibroblast cells, 2100 MHz EMF exposure for 2 hours was associated with increased cell viability and increased NF-κB and DNMT activities versus control. Co-treatment with zinc (50, 100, or 200 µM) plus 2100 MHz EMF was associated with decreased …

Study snapshot

PublicationElectromagnetic biology and medicine · 2022
Study typein_vitro
Reported directionMixed
Evidence ratingLow

Abstract

Zinc affects nuclear factor kappa b and DNA methyltransferase activity in C3H cancer fibroblast cells induced by a 2100 MHz electromagnetic field D Duzgun Ergun, N Pastaci Ozsobaci, T Yilmaz, D Ozcelik, M T Kalkan. Zinc affects nuclear factor kappa b and DNA methyltransferase activity in C3H cancer fibroblast cells induced by a 2100 MHz electromagnetic field. Electromagn Biol Med. 2022 Jan 7;1-8. doi: 10.1080/15368378.2021.2019760. Abstract The use of mobile phones is becoming widespread with the development of technology, and as a result, its effects on human health are becoming more and more important every day. Studies have reported that the electromagnetic field (EMF) emitted by mobile phones may have adverse effects on the biological systems. In order to evaluate the effect of zinc (Zn) on C3H cancer fibroblast cells exposed to 2100 MHz EMF, we analyzed cell viability%, nuclear factor kappa b (NF-κB) and DNA methyltransferase (DNMT) activities. Cells were divided to following groups: Control, sham control, 2100 MHz EMF, 50 µM Zn + 2100 MHz EMF, 100 µM Zn + 2100 MHz EMF, and 200 µM Zn + 2100 MHz EMF for 2 h. We measurement cell viability, NF-κB and DNMT activities. There was increased cell viability % in the 2100 MHz EMF group compared to the control group, while the cell viability % was decreased in the 50, 100 and 200 µM Zn + 2100 MHz EMF groups compared to 2100 MHz EMF. NF-κB and DNMT activities were a significant increase in the 2100 MHz EMF group compared to the control group, although were statistically decreased in the 50, 100 and 200 µM Zn + 2100 MHz EMF groups compared to the 2100 MHz EMF group. Our results demonstrate that 2100 MHz EMF exposure in cancer fibroblast cells induce NF-κB and DNMT activities, whereas zinc supplementation reduce NF-κB and DNMT activities-induced 2100 MHz EMF. pubmed.ncbi.nlm.nih.gov

Machine Enhanced Logic

AI evidence extraction

Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.

Study typein_vitro
Effect directionmixed
PopulationC3H cancer fibroblast cells
Sample sizeNot supplied
ExposureRF · 2100 MHz · 2 h
Evidence strengthLowConfidence: 74% · Peer reviewed: yes

Main findings

In C3H cancer fibroblast cells, 2100 MHz EMF exposure for 2 hours was associated with increased cell viability and increased NF-κB and DNMT activities versus control. Co-treatment with zinc (50, 100, or 200 µM) plus 2100 MHz EMF was associated with decreased cell viability and decreased NF-κB and DNMT activities compared with the EMF-only group.

Outcomes measured

  • Cell viability
  • NF-κB activity
  • DNA methyltransferase (DNMT) activity

Limitations

  • In vitro cell model; findings may not translate to humans or real-world exposures.
  • No sample size or replication details provided in the abstract.
  • Exposure metric (e.g., SAR) and dosimetry details are not reported in the abstract.
  • Only short-term (2 h) exposure assessed.
  • Zinc was tested only in combination with EMF; zinc-only effects are not described in the abstract.
View raw extracted JSON
{
  "publication_year": null,
  "study_type": "in_vitro",
  "exposure": {
    "band": "RF",
    "source": "mobile phone",
    "frequency_mhz": 2100,
    "sar_wkg": null,
    "duration": "2 h"
  },
  "population": "C3H cancer fibroblast cells",
  "sample_size": null,
  "outcomes": [
    "Cell viability",
    "NF-κB activity",
    "DNA methyltransferase (DNMT) activity"
  ],
  "main_findings": "In C3H cancer fibroblast cells, 2100 MHz EMF exposure for 2 hours was associated with increased cell viability and increased NF-κB and DNMT activities versus control. Co-treatment with zinc (50, 100, or 200 µM) plus 2100 MHz EMF was associated with decreased cell viability and decreased NF-κB and DNMT activities compared with the EMF-only group.",
  "effect_direction": "mixed",
  "limitations": [
    "In vitro cell model; findings may not translate to humans or real-world exposures.",
    "No sample size or replication details provided in the abstract.",
    "Exposure metric (e.g., SAR) and dosimetry details are not reported in the abstract.",
    "Only short-term (2 h) exposure assessed.",
    "Zinc was tested only in combination with EMF; zinc-only effects are not described in the abstract."
  ],
  "evidence_strength": "low",
  "confidence": 0.74,
  "peer_reviewed_likely": "yes",
  "stance": "concern",
  "stance_confidence": 0.66,
  "summary": "This in vitro study examined C3H cancer fibroblast cells exposed to a 2100 MHz electromagnetic field for 2 hours, with or without zinc supplementation. The abstract reports increased cell viability and increased NF-κB and DNMT activities in the EMF-only group versus control. Zinc co-treatment (50–200 µM) was reported to reduce NF-κB and DNMT activities and reduce viability compared with EMF-only.",
  "key_points": [
    "The study used an in vitro C3H cancer fibroblast cell model.",
    "Cells were exposed to 2100 MHz EMF for 2 hours, with control and sham control groups.",
    "EMF exposure was reported to increase cell viability compared with control.",
    "EMF exposure was reported to increase NF-κB and DNMT activities compared with control.",
    "Zinc (50–200 µM) combined with EMF was reported to decrease viability compared with EMF-only.",
    "Zinc combined with EMF was reported to decrease NF-κB and DNMT activities compared with EMF-only."
  ],
  "categories": [
    "RF-EMF",
    "Mobile Phones",
    "In Vitro",
    "Molecular Biology",
    "Epigenetics"
  ],
  "tags": [
    "2100 MHz",
    "RF-EMF",
    "Mobile Phone Radiation",
    "Cancer Fibroblast Cells",
    "C3H Cells",
    "Zinc Supplementation",
    "NF-kappaB",
    "DNA Methyltransferase",
    "DNMT Activity",
    "Cell Viability",
    "Epigenetic Enzymes",
    "Inflammatory Signaling"
  ],
  "keywords": [
    "2100 MHz",
    "electromagnetic field",
    "EMF",
    "mobile phones",
    "zinc",
    "Zn",
    "C3H cancer fibroblast cells",
    "cell viability",
    "NF-κB",
    "nuclear factor kappa b",
    "DNMT",
    "DNA methyltransferase"
  ],
  "suggested_hubs": [
    {
      "slug": "cell-phones",
      "weight": 0.86,
      "reason": "The abstract frames the 2100 MHz EMF as emitted by mobile phones and studies cellular responses to this exposure."
    }
  ],
  "social": {
    "tweet": "In C3H cancer fibroblast cells, 2 h exposure to 2100 MHz EMF was reported to increase NF-κB and DNMT activities and cell viability vs control; zinc (50–200 µM) co-treatment reduced these measures vs EMF-only (in vitro study).",
    "facebook": "An in vitro study in C3H cancer fibroblast cells reported that 2 hours of 2100 MHz EMF exposure increased cell viability and increased NF-κB and DNA methyltransferase (DNMT) activities compared with control. Zinc co-treatment (50–200 µM) was reported to reduce NF-κB and DNMT activities and reduce viability compared with EMF-only.",
    "linkedin": "This in vitro paper reports that 2100 MHz EMF exposure for 2 hours increased NF-κB and DNMT activities and cell viability in C3H cancer fibroblast cells versus control. Zinc (50–200 µM) co-treatment was reported to attenuate NF-κB and DNMT activity increases compared with EMF-only, highlighting a potential modulatory role of zinc under these experimental conditions."
  }
}
AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.

Identifiers and source

DOI: 10.1080/15368378.2021.2019760
PubMed: 34994293

Read the original paper →

Related papers

← Back to the Research Library